Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials
S Sahay, L Nombela-Franco, J Rodes-Cabau… - Heart, 2017 - heart.bmj.com
Background The effectiveness of vitamin K antagonist (VKA) versus placebo and antiplatelet
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomized trials
S Sahay - heart.bmj.com
Database: MEDLINE-PubMed# 1 randomized controlled trial (clinical trial, phase III)("
randomized controlled trial"[Publication Type] OR" randomized controlled trials as …
randomized controlled trial"[Publication Type] OR" randomized controlled trials as …
[PDF][PDF] Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials
S Sahay, L Nombela-Franco, J Rodes-Cabau… - 2016 - scholar.archive.org
Background The effectiveness of vitamin K antagonist (VKA) versus placebo and antiplatelet
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
S Sahay, L Nombela-Franco… - Heart (British Cardiac …, 2016 - europepmc.org
Background The effectiveness of vitamin K antagonist (VKA) versus placebo and antiplatelet
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials
S Sahay, L Nombela-Franco, J Rodes-Cabau… - Heart, 2017 - search.proquest.com
Background The effectiveness of vitamin K antagonist (VKA) versus placebo and antiplatelet
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
[引用][C] Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: A network meta-analysis from randomised trials
S Sahay, L Nombela-Franco, J Rodes-Cabau… - Heart, 2017 - produccioncientifica.ucm.es
Background The effectiveness of vitamin K antagonist (VKA) versus placebo and antiplatelet
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials
S Sahay, L Nombela-Franco… - Heart (British …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The effectiveness of vitamin K antagonist (VKA) versus placebo and antiplatelet
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
[PDF][PDF] Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials
S Sahay, L Nombela-Franco, J Rodes-Cabau… - 2016 - academia.edu
Background The effectiveness of vitamin K antagonist (VKA) versus placebo and antiplatelet
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …
therapy (APT) is well established for stroke prevention in atrial fibrillation (AF). Non-vitamin K …